NCT06495645Recruiting
Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy
Computer-aided Gastric Lesion Localization and Miss Rate of Gastric Neoplasms: a Tandem, Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 20 Nov 2025
Brief summary (registry, in English)
This prospective randomized trial compares AI-assisted upper gastrointestinal endoscopy with high definition upper gastrointestinal endoscopy in term of missed rate of gastric neoplasm. The investigators hypothesize the miss rate of high definition upper gastrointestinal endoscopy is higher than AI-assisted upper gastrointestinal endoscopy.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1000 (estimated)
- First submitted
- 25 Jun 2024
- Start date
- 1 Nov 2024
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- The University of Hong Kong
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06495645
What you commit to
- Study type: Interventional
- Planned participants: 1000
- From 1 Nov 2024 to the primary completion date, 1 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior gastrectomy, and
Other illness
- Patients deemed unsuitable or high-risk for endoscopy with severe comorbid illnesses
Other
- Pregnant women,
- Inability to provide written informed consent
Who the study is looking for
- Patients aged 40 or older
- Scheduled for elective upper endoscopy
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Queen Mary Hospital, The University of Hong Kong Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.